Rock Springs Capital Management LP Icosavax, Inc. Transaction History

Rock Springs Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$4.89 - $10.57 $19,066 - $41,212	3,899 Added 0.45%	868,409 $8.62 Million
Q1 2023 May 15, 2023	BUY	$5.62 - $11.51 $469,326 - $961,200	83,510 Added 10.69%	864,510 $5.01 Million
Q3 2022 Nov 14, 2022	BUY	$3.09 - $9.21 $60,078 - $179,070	19,443 Added 2.55%	781,000 $2.47 Million
Q1 2022 May 16, 2022	BUY	$4.41 - $22.5 $114,893 - $586,192	26,053 Added 3.54%	761,557 $5.36 Million
Q4 2021 Feb 14, 2022	BUY	$21.07 - $34.98 $27,159 - $45,089	1,289 Added 0.18%	735,504 $16.8 Million
Q3 2021 Nov 15, 2021	BUY	$24.85 - $40.25 $18.2 Million - $29.6 Million	734,215 New	734,215 $21.7 Million

1.37M

Ticker ICVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,885,200
Description
Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical tri...

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rock Springs Capital Management LP with notifications on news.